Literature DB >> 11669161

Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus.

D D Gladman1, V Chaudhry-Ahluwalia, D Ibañez, E Bogoch, M B Urowitz.   

Abstract

OBJECTIVE: To describe the frequency and type of symptomatic osteonecrosis (ON) in a large cohort of patients with systemic lupus erythematosus (SLE) followed in a single center and to describe the outcome in terms of mortality and disability compared to SLE patients without ON.
METHODS: Patients with ON were identified from the University of Toronto Lupus Clinic Database. The diagnosis of ON was confirmed by radiographs, bone scans, tomograms, or magnetic resonance images. A comparison group of patients with SLE without ON was selected from the same database, matched by year of birth, sex, and year of entry to the clinic. Mortality, disability, and health related quality of life were compared between patients with and without ON.
RESULTS: Ninety-nine patients with ON were identified with 217 affected joints, the majority hips and knees, often in a bilateral distribution. There was no increase in mortality. Patients with ON had higher Health Assessment Questionnaire scores and lower SF-20 scores of physical functioning, suggesting increased disability. Hip joints that underwent surgery were more likely to have higher grades of ON at diagnosis.
CONCLUSION: Symptomatic ON occurred in 12.8% of 744 patients with SLE and often involved multiple joints. ON was not associated with increased mortality but was associated with physical disability. Radiological class of the hip jointsat diagnosis of ON was predictive of subsequent surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669161

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Rapidly destructive arthrosis of the hip joint in a young adult with systemic lupus erythematosus.

Authors:  Yongseung Lee; Goro Motomura; Takuaki Yamamoto; Yasuharu Nakashima; Masanobu Ohishi; Satoshi Hamai; Kunio Iura; Yukihide Iwamoto
Journal:  Rheumatol Int       Date:  2015-06-05       Impact factor: 2.631

2.  Manifestations of systemic lupus erythematosus.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-10

Review 3.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

4.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.

Authors:  J Calvo-Alén; G McGwin; S Toloza; M Fernández; J M Roseman; H M Bastian; E J Cepeda; E B González; B A Baethge; B J Fessler; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

Review 5.  Osteonecrosis in patients with SLE.

Authors:  Mahmoud Abu-Shakra; Dan Buskila; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

6.  Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.

Authors:  Mehmet Sayarlioglu; Nergis Yuzbasioglu; Murat Inanc; Sevil Kamali; Ayse Cefle; Ozcan Karaman; Ahmet Mesut Onat; Rustem Avan; Gozde Yildirm Cetin; Ahmet Gul; Lale Ocal; Orhan Aral
Journal:  Rheumatol Int       Date:  2010-08-15       Impact factor: 2.631

7.  Long-Term Survivorship and Clinical Outcomes of Osteochondral Autologous Transplantation for Steroid-Induced Osteonecrosis of the Knee.

Authors:  Kohei Nishitani; Yasuaki Nakagawa; Masahiko Kobayashi; Shinichiro Nakamura; Shogo Mukai; Shinichi Kuriyama; Shuichi Matsuda
Journal:  Cartilage       Date:  2020-09-10       Impact factor: 3.117

Review 8.  Treatment of osteonecrosis in systemic lupus erythematosus: a review.

Authors:  T Andrew Ehmke; Jeffrey J Cherian; Eddie S Wu; Julio J Jauregui; Samik Banerjee; Michael A Mont
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

9.  Glucocorticoid-induced avascular bone necrosis: diagnosis and management.

Authors:  K L Chan; C C Mok
Journal:  Open Orthop J       Date:  2012-10-05

10.  Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication.

Authors:  Paola Caramaschi; Domenico Biasi; Ilaria Dal Forno; Silvano Adami
Journal:  Autoimmune Dis       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.